Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma - 19/04/18
, David Xiong, BA a, Jason Ya, BS a, Pauline Funchain, MD b, Raymond Isakov, MD c, Brian Gastman, MD c, Alok Vij, MD aAbstract |
Background |
Sentinel lymph node (SLN) biopsy is widely performed for melanoma with certain histologic parameters and offers important prognostic and staging information. Breslow thickness (BT) by itself also provides meaningful prognostic information.
Objective |
To evaluate whether SLN status provides prognostic information independent from that which is already provided by BT.
Methods |
We conducted a retrospective cohort study of 896 patients who underwent SLN biopsy for primary cutaneous melanoma. Stratified analysis of the impact of SLN status within BT groups (0.01-1 mm, 1.01-2.00 mm, 2.01-4.00 mm, and >4.00 mm) was performed. In addition, a Cox proportional hazard model was fit to evaluate the interaction between BT unadjusted and then adjusted for SLN status to determine whether predictive ability is improved.
Results |
Having a negative SLN did not confer a statistically significant survival advantage for any BT subgroup (P = .54, .075, .17, and .95 for subgroups 0.01-1 mm, 1.01-2.00 mm, 2.01-4.00 mm, and >4.00 mm, respectively). In multivariate analysis, SLN status did not demonstrate independent prognostic ability over that of BT alone (P = .067).
Limitations |
Retrospective study, single institution.
Conclusion |
Our data suggest that SLN status does not offer better prognostic information for patients than BT alone.
Le texte complet de cet article est disponible en PDF.Key words : Breslow thickness, melanoma, melanoma prognosis, sentinel lymph node biopsy
Abbreviations used : BT, GEP, MSLT-1, OS, SLN, SLNB
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
|
| Reprints not available from the authors. |
Vol 78 - N° 5
P. 942-948 - mai 2018 Retour au numéro
Article précédent
- Mitotic rate is associated with positive lymph nodes in patients with thin melanomas
- Lee Wheless, Chelsea A. Isom, Mary A. Hooks, Rondi M. Kauffmann
- Postdiagnosis aspirin use and overall survival in patients with melanoma
- Saleh Rachidi, Kristin Wallace, Hong Li, Tim Lautenschlaeger, Zihai Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?